{"id":"NCT02979613","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed","officialTitle":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching From Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25 mg QD in Subjects With Chronic Hepatitis B Who Are Virologically Suppressed","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-29","primaryCompletion":"2018-09-10","completion":"2020-01-30","firstPosted":"2016-12-01","resultsPosted":"2019-09-25","lastUpdate":"2020-09-14"},"enrollment":490,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis B"],"interventions":[{"type":"DRUG","name":"TAF","otherNames":["Vemlidy®","GS-7340"]},{"type":"DRUG","name":"TDF","otherNames":["Viread®"]},{"type":"DRUG","name":"TAF Placebo","otherNames":[]},{"type":"DRUG","name":"TDF Placebo","otherNames":[]}],"arms":[{"label":"TAF 25 mg","type":"EXPERIMENTAL"},{"label":"TDF 300 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of switching to tenofovir alafenamide (TAF) versus continuing tenofovir disoproxil fumarate (TDF) in virologically suppressed adults with chronic hepatitis B virus (HBV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Hepatitis B Virus (HBV) DNA Levels ≥ 20 IU/mL at Week 48, as Determined by the Modified United States Food and Drug Administration (US FDA)-Defined Snapshot Algorithm","timeFrame":"Week 48","effectByArm":[{"arm":"TAF 25 mg","deltaMin":0.4,"sd":null},{"arm":"TDF 300 mg","deltaMin":0.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":39,"countries":["United States","Canada","Hong Kong","Italy","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["32087795"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":243},"commonTop":["Upper respiratory tract infection","Nasopharyngitis"]}}